Posts Tagged ‘cell therapy’

The “immunity saboteurs ” – otherwise known as T-cells

Author: Hamideh Emrani, 06/07/17

Did you know that a healthy person with a healthy lifestyle and diet might still end up being diabetic? That is certainly the case with those who have type 1 diabetes (T1D). In T1D, the patient’s body has lost the ability to produce insulin. Insulin is a hormone that acts like an agent and takes…Read more

Cells…in a box

Author: Guest, 02/13/17

Heather Blumenthal has been writing about health and health research for more than 20 years and never loses her fascination with the advances Canadian researchers are making. You can reach her at hblumenthal@sympatico.ca It’s like magic – insert a cancer patient’s blood cells in one end and out the other end come T-cells adapted for…Read more

Right Turn: The story of scurvy is a poignant cautionary tale for modern medical science

Author: Guest, 11/04/16

Elizabeth (Liz) Csaszar is a development manager for the BridGE team at CCRM. Her areas of interest are cell manufacturing, clinical translation of cell based therapies, and blood cell technologies. Liz obtained her PhD at the University of Toronto, focusing on the strategies to expand and self-renew hematopoietic stem cells in vitro. Liz is interested in…Read more

A double duty scaffold for cell delivery to the brain

Author: Samantha Payne, 04/07/16

Neurodegenerative diseases of the brain, such as Parkinson’s and Alzheimer’s, are a leading cause of disability in Canada, but despite the significant burden on patients, caregivers and the health-care system, we still lack a cure. An active area of research for these diseases is focused on the transplantation of exogenous cells to replace degenerated neurons…Read more

What do car (and CAR) choices have to do with cell therapies?

Author: James Smith, 03/07/16

Post by James Smith and Mackenna Roberts. Ms. Roberts is an English-qualified lawyer, trained bioethicist and strategic adviser for the commercialization of emerging biomedical technologies and is widely published on how the law should govern cutting-edge medical therapies. She is an associate at IP Asset Partnership Ltd in London, IP consultant to IP Asset Ventures…Read more

Here we go…cells derived from embryonic stem cells in UK clinics

Author: David Kent, 11/16/15

The United Kingdom has begun its foray into using cells derived from human embryonic stem cells (ESCs) in clinical settings. I have to admit I was surprised that following coverage on the BBC and in The Guardian, there was virtually no anti-ESC protesting to be found, especially considering this was the first human ESC therapy…Read more

Skin stem cells provide hope for treating burn victims

Author: Nicole Forgione, 11/03/15

At one point or another we’ve all experienced a bad haircut. We get over such minor annoyances secure in the knowledge that “it will grow back.” The ability of our hair to grow back is based on the amazing capacity of the hair follicle to undergo continuous cycles of growth and regrowth throughout our lifetime….Read more

Such a long journey – Europe approves retinal cell therapy based on decades of good science

Author: David Kent, 03/24/15

> At one of my very first Canadian Stem Cell Network Annual General Meetings, when I was just a couple of years into my stem cell biology training, I remember sitting down just after lunch when a jovial Italian man sauntered up to the stage and apologized to the audience for the timing of his…Read more

Cell Therapy 2.0 – warts and all

Author: David Kent, 03/16/15

> The last 15 years of stem cell research have been full of hope and promises – some of it delivered upon, most of it not quite there yet, and some of it miserably failed. I guess that is to be expected in a highly experimental area of medicine, but one of the most striking…Read more

Beta cell transplant, hype or hope?

Author: Mark Curtis, 12/04/14

. The Edmonton Protocol for the transplantation of insulin producing cells into individuals with type 1 diabetes (T1DM) has a cost per quality-adjusted life year (QALY) of ~$165,000. This is more than three times the willingness-to-pay (WTP) in Canada, and comfortably twice the WTP in the United States for many health care insurance plans. Even…Read more